Oncology
Christopher Lathan, M.D. M.S. M.P.H.
Chair at Dana Farber, and he serves as Dana-Farber’s Chief Clinical Access Officer. He is the Founding Director of Dana-Farber’s Cancer Care Access Program; Chief Medical Officer and Medical Director of Dana-Farber Cancer Institute’s Regional Campuses and currently serves as the chair for American Society of Cl
Dr. Christopher Lathan is a medical oncology specialist at Dana-Farber Cancer Institute specializing in General medical oncology, Lung cancer, Midline NUT carcinoma, Racial disparities in lung cancer treatment, serving as Chair at Dana Farber, and he serves as Dana-Farber’s Chief Clinical Access Officer. He is the Founding Director of Dana-Farber’s Cancer Care Access Program; Chief Medical Officer and Medical Director of Dana-Farber Cancer Institute’s Regional Campuses and currently serves as th
25+
Years in Practice
Credentials
Board Certifications
- Medical Oncology
Education & Training
- Tufts University School of Medicine (MD)
- Boston Medical Center, Chief Medical Resident (Residency)
- Boston Medical Center, Internal Medicine (Residency)
- Dana-Farber/Partners CancerCare, Medical Oncology (Fellowship)
Clinical Focus
Subspecialties
Conditions & Treatments
Practice Details
Hospital Affiliations
- Dana-Farber Cancer Institute
Experience
25+ years in practice